Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with endometrial (uterine) cancer that has not spread beyond the uterus, confirmed by a tissue sample (biopsy), and who are being considered for surgery
- People whose endometrial cancer falls into one of the following categories: a higher-grade (more aggressive) type called endometrioid, a cancer with a specific gene change called a P53 mutation, or a cancer type that is not endometrioid (regardless of P53 mutation status)
- People who are enrolled in a social security (health insurance) scheme
- People who have been fully informed about the study and have signed a consent form before any study procedures begin
Who may not be able to join:
- People who have had another active cancer diagnosed within the last 6 months (with the exception of a type of skin cancer called basal cell carcinoma that has already been treated)
- People who are in legal custody, under guardianship, subject to a legal protection order, or who are otherwise unable to give their own consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33231455050
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of establishment of exploitable tumor organoid lines
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.